Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Protokoll des Earnings Call: Hydreight Technologies mit Umsatzsprung in Q3 2025, Aktie unter Druck (Investing.com DE) +++ HYDREIGHT Aktie -26,47%

News zum Sektor Gesundheit aus Israel

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 103 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1574 Aktien zum Sektor Gesundheit bekannt.
 
26.11.25 - 14:42
 Galmed GAAP EPS of -$0.33 beats by $0.21 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.11.25 - 14:33
 Galmed Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
 
TEL AVIV, Israel, Nov. 26, 2025 /PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and gastrointestinal oncology indications, reports financial results for the three and nine......
26.11.25 - 14:03
 Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement (GlobeNewswire EN)
 
– Enlivex has adopted the world's first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation....
26.11.25 - 13:33
 COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
 
Expansion of rhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a U.S.-based logistics center scheduled to become operational this quarter and under new commercial leadership for this region Recent developments suggest......
25.11.25 - 14:03
 UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire EN)
 
PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the Piper Sandler 37th Annual Healthcare Conference to take place on December 2-4, 2025....
24.11.25 - 16:01
 Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors (PR Newswire)
 
Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation NESS ZIONA, Israel, Nov. 24, 2025 /PRNewswire/ -- Enlivex Therapeutics Ltd. (NASDAQ: ENLV) today announced the appointment of Mr.......
24.11.25 - 15:57
 NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS (PR Newswire)
 
CAMBRIDGE, Mass., Nov. 24, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has......
24.11.25 - 15:42
 Enlivex Therapeutics to raise $212M via PIPE for prediction-markets token treasury (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.11.25 - 13:57
 Enlivex Announces $212,000,000 Private Placement to Initiate World′s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board (GlobeNewswire EN)
 
- Upon the closing of the private placement, Enlivex will adopt the world's first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation....
24.11.25 - 12:57
 Enlivex stock gains on upbeat 6-month results in knee osteoarthritis trial (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.11.25 - 12:42
 Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis (GlobeNewswire EN)
 
Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive six-month efficacy data from the Phase IIa stage of its randomized, multi-country Phase I/II Allocetra™ trial (ENX-CL-05-001) in patients with moderate to severe knee osteoarthritis (OA). The six-month follow-up has now been completed for all patients. The results re-affirm the three-month data reported previously and substantiate the identification of an age-related primary OA responder population....
21.11.25 - 05:48
 Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound (RTTNews)
 
Trading after the bell was relatively muted on Thursday, with small-cap biotech names showing modest shifts. Delcath Systems edged higher following its buyback announcement, while BioVie, Cassava Sciences, and Enlivex Therapeutics rebounded despite a lack of fresh headlines....
20.11.25 - 16:00
 MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
 
MediWound (MDWD) delivered earnings and revenue surprises of +70.37% and -15.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
20.11.25 - 13:54
 Sol-Gel Technologies GAAP EPS of -$1.70, revenue of $11.26M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.11.25 - 13:33
 Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire EN)
 
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates...
20.11.25 - 13:09
 MediWound GAAP EPS of -$0.24 beats by $0.57, revenue of $5.43M misses by $1.13M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.11.25 - 13:03
 MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire EN)
 
Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers...
19.11.25 - 16:00
 MediWound Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Lebenstraum der meisten Österreicher ist, daß sie hinter dem Schreibtisch sitzen und sich an Paragraphen festhalten - das wollen wir ändern. - Dr. Josef Taus
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!